Template:SUIT-006 O2 mt D022: Difference between revisions

From Bioblast
No edit summary
No edit summary
ย 
(4 intermediate revisions by 4 users not shown)
Line 1: Line 1:
[[Image:SUIT-MitoFit.png|right|190px|link=http://www.bioblast.at/index.php/MitoPedia:_SUIT |MitoPedia: SUIT]]
[[Image:SUIT-MitoFit.png|right|190px|link=http://www.bioblast.at/index.php/MitoPedia:_SUIT |MitoPedia: SUIT]]
== Steps and respiratory states ==
== Steps and respiratory states ==
[[File:1SRot;2D;2c;3Omy;4U;5Ama.png|400px]]
[[File:1SRot;2D;2c;3(Omy);4U;5Ama.png|400px]]


{| class="wikitable" border="1"
{| class="wikitable" border="1"
Line 8: Line 8:
|-
|-
| 1SRot
| 1SRot
| [[S]]<sub>''[[L]]''</sub>
| [[S]]<sub>''[[LEAK respiration|L]]''</sub>
| [[S]]
| [[S]]
| CII
| CII
Line 39: Line 39:


|-
|-
| 3(Omy)
| (3Omy)
| [[PM]]<sub>[[L |''L''(Omy)]]</sub>
| [[S]]c<sub>''[[LEAK respiration|L]]''(Omy)</sub> ย 
| [[N]]
| ย 
| CII
| ย 
| 1SRot;2D;2c;3(Omy)
| 1SRot;2D;2c;(3Omy)


* Omy addition is skipped in SUIT-006 O2 mt D022
*{{Template:SUIT S}}
*{{Template:SUIT S}}
*{{Template:SUIT L(Omy)}} ย 
*{{Template:SUIT L(Omy)}}
*The addition of [[oligomycin]] is optional depending on the experimental question to resolve. If it is known that ''L''<sub>n</sub> has the same values for ''L''<sub>Omy</sub> for a kind of sample and substrates, this step may be skipped. If the carrier of oligomycin (EtOH) is used instead, it is possible to evaluate whether it affects respiration. In these cases, LEAK state is not reached again.


|-
|-
Line 54: Line 54:
| [[S]]
| [[S]]
| CII
| CII
| 1SRot;2D;2c;3(Omy);4U
| 1SRot;2D;2c;4U


*{{Template:SUIT S}}
*{{Template:SUIT S}}
Line 64: Line 64:
| ย 
| ย 
|ย  ย 
|ย  ย 
| 1SRot;2D;2c;3(Omy);4U;5Ama
| 1SRot;2D;2c;4U;5Ama


*{{Template:SUIT Ama}}
*{{Template:SUIT Ama}}


|}
|}
{{Template:Keywords in SUIT protocols}}
{{Keywords: SUIT protocols}}

Latest revision as of 13:11, 25 November 2020

MitoPedia: SUIT

Steps and respiratory states

1SRot;2D;2c;3(Omy);4U;5Ama.png

Step State Pathway Q-junction Comment - Events (E) and Marks (M)
1SRot SL S CII 1SRot
2D SP S CII 1SRot;2D
2c ScP S CII 1SRot;2D;2c
(3Omy) ScL(Omy) 1SRot;2D;2c;(3Omy)
  • Omy addition is skipped in SUIT-006 O2 mt D022
  • Succinate, S ( type S-pathway to Q).
  • Non-phosphorylating resting state (LEAK state); LEAK-respiration, L(Omy), after blocking the ATP synthase with oligomycin.
4U SE S CII 1SRot;2D;2c;4U
5Ama ROX 1SRot;2D;2c;4U;5Ama
  • Rox is the residual oxygen consumption in the ROX state, due to oxidative side reactions, estimated after addition of antimycin A (inhibitor of CIII). Rox is subtracted from oxygen flux as a baseline for all respiratory states, to obtain mitochondrial respiration (mt).


Questions.jpg


Click to expand or collaps
Bioblast links: SUIT protocols - >>>>>>> - Click on [Expand] or [Collapse] - >>>>>>>
Cookies help us deliver our services. By using our services, you agree to our use of cookies.